Teva to Present at the Upcoming Investor Conferences in March

About this update from Teva Pharmaceutical Industries Limited

[{"type":"image","alt":"Teva Pharmaceutical Industries Ltd","displaySize":"","headline":null,"caption":"Teva Pharmaceutical Industries Ltd","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":108,"url":"https://media.zenfs.com/en/globenewswire.com/bfbffad044ba3112cbe08e7be13bb2e7"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/vrlzyJKRPwSh_YtGafCgLw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE1MTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/bfbffad044ba3112cbe08e7be13bb2e7","width":300,"height":108}},"lazy":false},{"type":"text","content":"PARSIPPANY, N.J. and TEL AVIV, Israel, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will participate in the upcoming investor conferences in March as follows:","length":273,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"UBS European Healthcare Conference Tuesday, March 3, 2026 (investor meetings only – no webcast)","length":96,"tagName":"p"}]},{"val":[{"type":"text","content":"Leerink Partners Global Healthcare ConferenceMonday, March 9, 2026, at 10:00 am ET (webcast fireside chat)","length":107,"tagName":"p"}]},{"val":[{"type":"text","content":"Barclays 28th Annual Global Healthcare ConferenceTuesday, March 10, 2026, at 8:00 am ET (webcast fireside chat)","length":112,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":315,"olType":false},{"type":"text","content":"To access live webcasts of the presentations, please visit Teva’s Investor Relations website at https://ir.tevapharm.com/Events-and-Presentations.","length":146,"tagName":"p"},{"type":"text","content":"Archived versions of the webcasts will be available within 24 hours after the end of the live discussion and will be accessible for up to 30 days.","length":146,"tagName":"p"},{"type":"text","content":"About Teva","length":10,"tagName":"p"},{"type":"text","content":"Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is transforming into a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment to bettering health has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to a...

More updates from Teva Pharmaceutical Industries Limited